Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome

ISSN： 1401-7431

Source： Scandinavian Cardiovascular Journal, Vol.42, Iss.4, 2008-01, pp. : 256-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome

Current Diabetes Reviews, Vol. 9, Iss. 2, 2013-03 ,pp. : 137-145

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Pershadsingh Harrihar A.

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

The Metabolic Syndrome and Type 2 Diabetes: Epidemiological Figures and Country Specificities

Cerebrovascular Diseases, Vol. 20, Iss. 1, 2005-11 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Association of Serum Uric Acid and Metabolic Syndrome in Type 2 Diabetes

Current Diabetes Reviews, Vol. 10, Iss. 2, 2014-03 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Review of Evidence that Epidemics of Type 1 Diabetes and Type 2 Diabetes/ Metabolic Syndrome are Polar Opposite Responses to Iatrogenic Inflammation

Current Diabetes Reviews, Vol. 8, Iss. 6, 2012-11 ,pp. : 413-418

Bentham Science Publishers

Access to resources Recommend Favorite